Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases SEBI SEBI + HC SEBI - 2024 (11) TMI HC This

  • Login
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2024 (11) TMI 617 - HC - SEBI


Issues Involved:

1. Whether the petitioner, as an executive director, can be held liable for the alleged fraudulent activities of the company.
2. Whether the proceedings against the petitioner should be quashed based on his role and responsibilities within the company.
3. The applicability of vicarious liability under the SEBI Act and the Companies Act in relation to the petitioner's position.

Detailed Analysis:

1. Liability of the Petitioner as an Executive Director:

The core issue revolves around whether the petitioner, who served as an executive director of Amrit Bio Energy and Industries Limited, can be held liable for the company's alleged fraudulent activities. The petitioner was appointed as an executive director on April 27, 2004, and resigned on October 8, 2013. The alleged offenses occurred during the financial years 2007-2011, within the petitioner's tenure. The court noted that a company, being a juristic person, acts through its officers; hence, those responsible for the company's conduct at the time of the offense may be held liable. The court emphasized that liability arises from being in charge of and responsible for the company's business conduct at the relevant time, not merely from holding a title.

2. Quashing of Proceedings Against the Petitioner:

The petitioner argued for the quashing of proceedings, claiming he was not involved in the day-to-day affairs of the company and only received a salary of Rs. 25,000. However, the court found a prima facie case against the petitioner, as he was a member of the Board of Directors during the period of the alleged offense. The court referenced precedents, such as S.M.S. Pharmaceuticals Ltd. v. Neeta Bhalla, which clarified that only those in charge of and responsible for the company's business at the time of the offense could be held liable. The court concluded that the petitioner's long tenure as director and the prima facie evidence supported the continuation of proceedings.

3. Applicability of Vicarious Liability:

The judgment discussed the principles of vicarious liability under the SEBI Act and the Companies Act, focusing on the petitioner's role. It cited various Supreme Court judgments, including K.K. Ahuja v. V.K. Vora, which outlined that a director could be held liable if they were in charge of and responsible for the company's business when the offense occurred. The court determined that the petitioner's role as an executive director and board member during the relevant period justified the proceedings against him. The court also noted that the trial stage, involving evidence examination, was not appropriate for quashing the proceedings based on the petitioner's claims.

Conclusion:

The court dismissed the revisional application, affirming that there was a prima facie case against the petitioner. It held that interfering with the trial proceedings would be an abuse of the process of law. The trial was directed to proceed expeditiously, with the court emphasizing the need for evidence to determine the petitioner's actual involvement and responsibility. The judgment underscores the legal principles of vicarious liability and the need for evidence to substantiate claims of non-involvement in corporate offenses.

 

 

 

 

Quick Updates:Latest Updates